News | Press Release
December 1, 2013
FIRST-EVER REAL-TIME MONITORING OF SKIN RADIATION EXPOSURE OPTIMIZES DOSE MANAGEMENT FOR PATIENTS
Safer Interventional Procedures with Toshiba’s Industry-First Dose Tracking System
CHICAGO, Dec. 1, 2013 – For the first time ever, clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba’s Dose Tracking System, an application soon to be available with Toshiba’s Infinix™-i Angiography systems for use in pediatric and adult cardiac and abdominal procedures (availability in Canada pending Health Canada license). The new technology is Toshiba’s latest advancement in optimizing dose management to improve patient safety.
Toshiba’s Dose Tracking System displays live and cumulative radiation exposure through an intuitive, color-coded indicator on a 3D visual representation of the patient. The display shows where the radiation is being administered on the patient’s body in real time. This alerts the clinician throughout a procedure to make quick and necessary changes to distribute the skin dose and minimize the potential risk of locally concentrated high exposure.
Toshiba partnered with the University of Buffalo to design the Dose Tracking System as an easy-to-understand visual aid that allows hospitals to suppress radiation exposure. In addition to the Dose Tracking System, other dose management tools like Spot Fluoroscopy offer a more complete picture and better manage radiation exposure, making procedures safer for patients and hospital staff. These dose reduction technologies, combined with the Infinix-i’s unmatched flexibility in system design, offer a perfect solution for today’s interventional procedures.
Toshiba showcased the Dose Tracking System, Spot Fluoroscopy and an enhanced processor for the Infinix-i at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Dec. 1–6, 2013 (Booth #7330, North Hall).
About Toshiba of Canada Limited, Medical Systems Division
With headquarters in Markham, Ontario, Toshiba of Canada Limited, Medical Systems Division (TCL), markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in Canada. For more information, visit the TCL Medical Systems Division website at www.toshiba-medical.ca
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
About Toshiba
Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society. Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
